DOI: 10.36347/sjams.2023.v11i12.019

Pages: 2106-2112

Introduction: Prostate cancer (PCa) is the second most common cancer in men, behind lung cancer. Bone scintigraphy (BS) is available, accessible and easy to perform, making it the test of choice for the detection of bone metastases for all cancers. We proposed to clarify the contribution of SO in the initial expansion report of the PCa in Burkina Faso. Materials and Method: We carried out a retrospective single-center descriptive cross-sectional study over the period from January 1, 2018 to January 1, 2021. It included the files of patients with CaP confirmed on histology and scored according to the Gleason score in whom an OS was performed. Demographic and histological variables were entered on the scintigraphic examination request forms. The descriptive study consisted of calculating frequencies for qualitative variables and means for quantitative variables. The comparison of variables was made using the Chi-Square contingency or Fisher tests depending on their conditions of applicability. The test was significant if p ≤0.05. Results: We collected 71 patient files, all with histologically confirmed prostate adenocarcinoma and initial BS. Their average age is 68.81 ± 8.70 years. The extreme ages were 50 and 88 years. Patients aged 60 to 70 were the most represented (38%). The PSA level ranged from 4.8 to 1030 with a mean PSA level of 304.94 ± 332.70 ng/ml. 34 patients had a Gleason score ≤ 6 (47.88%): Group A; 35 patients had a Gleason score between 6 and 8 (49.29%): Group B; 02 patients had a Gleason score greater than 8 (2.81%): Group C. BS+ were 46 (64.78%) patients compared to 25 BS- (35.21%). All patients with a Gleason score 6 are classified BS-. Among the 35 patients with a Gleason score = 6, 48.57% had BS+ and 51.42% had BS–. Among the 35 patients with a Gleason score between 7 and 8; 80% had an BS+ and 20% an BS-. The only patient with a Gleason score between 9 and 10 had BS+. Conclusion: Our study shows that OS+ is associated with an age greater than ....